Table 2.
Clinical characteristics of group with SBM
| Percent of SBM participants (n = 64a) | |
|---|---|
| Lesion level | |
| Above L1 | 0.17 |
| Below T12 | 0.83 |
| Chiari malformation | |
| None | 0.08 |
| I | 0.02 |
| II | 0.91 |
| Corpus callosum | |
| Normal | 0.02 |
| Hypoplastic | 0.66 |
| Dysgenetic | 0.33 |
| Shunt revisions | |
| 0 | 0.11 |
| 1 | 0.26 |
| 2–4 | 0.51 |
| 5–9 | 0.10 |
| >10 | 0.02 |
| Ambulatory status | |
| Normal | 0.03 |
| Independent | 0.31 |
| With support | 0.33 |
| Unable | 0.33 |
| Seizure disorder | |
| No | 0.85 |
| Past | 0.11 |
| Present | 0.04 |
Note. SBM, spina bifida myelomeningocele.
aParticipants missing data for shunt revisions: n= 3; ambulatory status: n= 3; seizure disorder: n= 11; participants missing data were not included in percentage calculations.